HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinichi Toyooka Selected Research

Tegafur

11/2019Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
1/2018A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
10/2009Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
9/2007Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinichi Toyooka Research Topics

Disease

143Neoplasms (Cancer)
05/2024 - 02/2002
115Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2003
83Lung Neoplasms (Lung Cancer)
04/2024 - 01/2002
22Neoplasm Metastasis (Metastasis)
12/2023 - 08/2005
21Breast Neoplasms (Breast Cancer)
01/2023 - 08/2002
17Malignant Mesothelioma
02/2024 - 02/2004
12Adenocarcinoma of Lung
06/2020 - 03/2005
10Adenocarcinoma
10/2023 - 01/2003
8Interstitial Lung Diseases (Interstitial Lung Disease)
01/2023 - 04/2006
8Colorectal Neoplasms (Colorectal Cancer)
07/2012 - 06/2002
7Sarcoma (Soft Tissue Sarcoma)
04/2024 - 02/2016
7Primary Graft Dysfunction
02/2024 - 10/2018
7Infections
01/2024 - 01/2016
6Radiation Pneumonitis
03/2024 - 10/2018
6Carcinoma (Carcinomatosis)
01/2024 - 08/2002
6Lung Injury
10/2023 - 06/2010
6Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2023 - 12/2008
6Hemorrhage
01/2023 - 01/2008
6Reperfusion Injury
10/2021 - 03/2012
6Pneumothorax
04/2020 - 01/2013
6Pleural Effusion (Pleural Effusions)
11/2019 - 09/2012
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017 - 12/2002
5COVID-19
11/2023 - 10/2022
5Bronchiolitis Obliterans Syndrome
11/2023 - 02/2022
5Disease Progression
12/2022 - 06/2007
5Melanoma (Melanoma, Malignant)
09/2022 - 07/2012
5Carcinogenesis
01/2022 - 05/2004
5Colonic Neoplasms (Colon Cancer)
05/2021 - 12/2002
5Stomach Neoplasms (Stomach Cancer)
08/2020 - 02/2007
4Lymphatic Metastasis
10/2023 - 05/2012
4Inflammation (Inflammations)
05/2023 - 04/2018
4Idiopathic Pulmonary Fibrosis
02/2022 - 04/2018
4Chylothorax
02/2020 - 08/2008
4Prostatic Neoplasms (Prostate Cancer)
07/2018 - 02/2002
4Mesothelioma
12/2016 - 06/2002
4Lymphoma (Lymphomas)
02/2016 - 08/2011
3Critical Illness (Critically Ill)
05/2024 - 08/2007
3Fibrosis (Cirrhosis)
12/2022 - 08/2020
3Ischemia
11/2022 - 01/2013
3Pulmonary Hypertension
10/2022 - 05/2010
3Edema (Dropsy)
10/2022 - 06/2010
3Empyema
10/2021 - 09/2012
3Sarcopenia
08/2021 - 01/2021
3Fistula
02/2021 - 03/2013
3Margins of Excision
03/2020 - 09/2012

Drug/Important Bio-Agent (IBA)

50ErbB Receptors (EGF Receptor)IBA
10/2023 - 11/2003
30Tyrosine Kinase InhibitorsIBA
01/2024 - 01/2006
20Gefitinib (Iressa)FDA Link
10/2023 - 02/2005
18Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2002
16Biomarkers (Surrogate Marker)IBA
05/2024 - 12/2002
13Messenger RNA (mRNA)IBA
11/2022 - 01/2003
12DNA (Deoxyribonucleic Acid)IBA
02/2024 - 03/2004
12Cisplatin (Platino)FDA LinkGeneric
12/2023 - 03/2008
11MicroRNAs (MicroRNA)IBA
04/2023 - 08/2011
11human ERBB2 proteinIBA
11/2021 - 02/2016
9Phosphotransferases (Kinase)IBA
02/2022 - 03/2005
8Docetaxel (Taxotere)FDA Link
06/2021 - 02/2010
7CytokinesIBA
10/2021 - 02/2005
6AfatinibIBA
08/2019 - 10/2015
6AsbestosIBA
05/2016 - 06/2002
5Cyclin-Dependent Kinase Inhibitor p16IBA
09/2009 - 02/2002
4CrizotinibIBA
01/2024 - 10/2014
4Hormones (Hormone)IBA
01/2023 - 01/2020
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022 - 03/2005
4Trastuzumab (Herceptin)FDA Link
11/2021 - 01/2017
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 11/2008
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2019 - 12/2016
4TegafurIBA
11/2019 - 09/2007
4UracilIBA
11/2019 - 09/2007
4Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
02/2016 - 01/2010
41-methyl-1-piperidinomethane sulfonateIBA
11/2015 - 02/2004
4Sirolimus (Rapamycin)FDA Link
07/2011 - 08/2008
4Codon (Codons)IBA
04/2007 - 03/2003
3Indicators and Reagents (Reagents)IBA
05/2024 - 05/2004
3Vinorelbine (Navelbine)FDA LinkGeneric
12/2023 - 01/2020
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2023 - 02/2012
3Ado-Trastuzumab EmtansineIBA
11/2021 - 01/2017
3Monoclonal AntibodiesIBA
10/2021 - 01/2019
3Estrogen ReceptorsIBA
03/2021 - 01/2010
3neratinibIBA
03/2020 - 04/2018

Therapy/Procedure

47Therapeutics
01/2024 - 08/2005
42Lung Transplantation
05/2024 - 07/2007
40Chemoradiotherapy
03/2024 - 08/2005
22Radiofrequency Ablation
10/2021 - 04/2007
16Drug Therapy (Chemotherapy)
10/2023 - 07/2007
13Adjuvant Chemotherapy
03/2024 - 09/2007
13Transplantation
09/2023 - 07/2007
11Radiotherapy
11/2021 - 12/2011
6Immunotherapy
09/2022 - 05/2004
5Pneumonectomy (Lung Volume Reduction)
02/2021 - 09/2012
5Chest Tubes (Chest Tube)
04/2020 - 01/2013
5Lymph Node Excision (Lymph Node Dissection)
03/2020 - 09/2007
4Perioperative Period
01/2024 - 09/2014
4Metastasectomy
12/2023 - 01/2021
4Neoadjuvant Therapy
01/2023 - 03/2008
4Operative Surgical Procedures
04/2018 - 07/2012
3Operative Time
04/2024 - 01/2023
3Thoracotomy
10/2023 - 07/2012
3Molecular Targeted Therapy
10/2022 - 03/2009
3Thymectomy
07/2022 - 01/2004